| Name | Title | Contact Details |
|---|
ViroChem Pharma is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
For pharmaceutical manufacturers and healthcare providers, AmerisourceBergen Specialty Group is an essential business partner.
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries.
Irix Pharmaceuticals is a Florence, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.